EUVIMEDEUVIMED entdecken
Open Access

DNA Damage and Nuclear Morphological Changes in Cardiac Hypertrophy Are Mediated by SNRK Through Actin Depolymerization

Paulina J Stanczyk, Yuki Tatekoshi iD, Jason S Shapiro, Krithika Nayudu iD, Yihan Chen, Zachary Zilber iD, Matthew Schipma iD, Adam De Jesus iD, Amir Mahmoodzadeh iD, Ashley Akrami, Hsiang-Chun Chang iD, Hossein Ardehali iD

Circulation · 14.11.2023 · 148 (20) · 1582-1592

DOI: 10.1161/circulationaha.123.066002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 14.11.2023. Verfasst von Paulina J Stanczyk und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, and Feinberg Cardiovascular and Renal Research Institute (P.J.S., Y.T., J.S.S., K.N., Y.C., Z.Z., A.D…. Hauptthemen laut MEDLINE: Actins, Cardiomegaly. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Proper nuclear organization is critical for cardiomyocyte function, because global structural remodeling of nuclear morphology and chromatin structure underpins the development and progression of cardiovascular disease. Previous reports have implicated a role for DNA damage in cardiac hypertrophy; however, the mechanism for this process is not well delineated. AMPK (AMP-activated protein kinase) family of proteins regulates metabolism and DNA damage response (DDR). Here, we examine whether a member of this family, SNRK (SNF1-related kinase), which plays a role in cardiac metabolism, is also involved in hypertrophic remodeling through changes in DDR and structural properties of the nucleus. METHODS: We subjected cardiac-specific Snrk –/– mice to transaortic banding to assess the effect on cardiac function and DDR. In parallel, we modulated SNRK in vitro and assessed its effects on DDR and nuclear parameters. We also used phosphoproteomics to identify novel proteins that are phosphorylated by SNRK. Last, coimmunoprecipitation was used to verify Destrin (DSTN) as the binding partner of SNRK that modulates its effects on the nucleus and DDR. RESULTS: Cardiac-specific Snrk –/– mice display worse cardiac function and cardiac hypertrophy in response to transaortic banding, and an increase in DDR marker pH2AX (phospho-histone 2AX) in their hearts. In addition, in vitro Snrk knockdown results in increased DNA damage and chromatin compaction, along with alterations in nuclear flatness and 3-dimensional volume. Phosphoproteomic studies identified a novel SNRK target, DSTN, a member of F-actin depolymerizing factor proteins that directly bind to and depolymerize F-actin. SNRK binds to DSTN, and DSTN downregulation reverses excess DNA damage and changes in nuclear parameters, in addition to cellular hypertrophy, with SNRK knockdown. We also demonstrate that SNRK knockdown promotes excessive actin depolymerization, measured by the increased ratio of G-actin to F-actin. Last, jasplakinolide, a pharmacological stabilizer of F-actin, rescues the increased DNA damage and aberrant nuclear morphology in SNRK-downregulated cells. CONCLUSIONS: These results indicate that SNRK is a key player in cardiac hypertrophy and DNA damage through its interaction with DSTN. This interaction fine-tunes actin polymerization to reduce DDR and maintain proper cardiomyocyte nuclear shape and morphology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ActinsCardiomegalyMiceAnimalsMyocytes, CardiacDNA DamageChromatinProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

AMP-activated protein kinasesDestrinactinshypertrophy, left ventricularmyocytes, cardiac

Substanzen

ActinsChromatinSnrk protein, mouseProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, and Feinberg Cardiovascular and Renal Research Institute (P.J.S., Y.T., J.S.S., K.N., Y.C., Z.Z., A.D.J., A.M., A.A., H.-C.C., H.A.), Northwestern University School of Med…
  • Department of Cardiovascular Sciences, University of Leicester, Leicester, UK (P.J.S.).
  • Department of Biochemistry and Molecular Genetics (M.A.), Northwestern University School of Medicine, Chicago, IL.

ORCID-Profile: Yuki Tatekoshi, Krithika Nayudu, Zachary Zilber, Matthew Schipma, Adam De Jesus, Amir Mahmoodzadeh, Hsiang-Chun Chang, Hossein Ardehali

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Stanczyk, P. J., Tatekoshi, Y., Shapiro, J. S., Nayudu, K., Chen, Y., Zilber, Z., Schipma, M., De Jesus, A., Mahmoodzadeh, A., Akrami, A., Chang, H. C., & Ardehali, H. (2023). DNA Damage and Nuclear Morphological Changes in Cardiac Hypertrophy Are Mediated by SNRK Through Actin Depolymerization. Circulation, 148(20), 1582-1592. https://doi.org/10.1161/circulationaha.123.066002

Vancouver

Stanczyk PJ, Tatekoshi Y, Shapiro JS, Nayudu K, Chen Y, Zilber Z, et al. DNA Damage and Nuclear Morphological Changes in Cardiac Hypertrophy Are Mediated by SNRK Through Actin Depolymerization. Circulation. 2023;148(20):1582-1592. doi:10.1161/circulationaha.123.066002

BibTeX
@article{Stanczyk2023,
  author = {Stanczyk, Paulina J and Tatekoshi, Yuki and Shapiro, Jason S and Nayudu, Krithika and Chen, Yihan and Zilber, Zachary and Schipma, Matthew and De Jesus, Adam and Mahmoodzadeh, Amir and Akrami, Ashley and Chang, Hsiang-Chun and Ardehali, Hossein},
  title = {DNA Damage and Nuclear Morphological Changes in Cardiac Hypertrophy Are Mediated by SNRK Through Actin Depolymerization},
  journal = {Circulation},
  year = {2023},
  volume = {148},
  number = {20},
  pages = {1582--1592},
  doi = {10.1161/circulationaha.123.066002}
}
Kostenlos starten →